555 related articles for article (PubMed ID: 19012362)
1. Thrombosis in systemic lupus erythematosus and other autoimmune diseases of recent onset.
Romero-Díaz J; García-Sosa I; Sánchez-Guerrero J
J Rheumatol; 2009 Jan; 36(1):68-75. PubMed ID: 19012362
[TBL] [Abstract][Full Text] [Related]
2. Antiphospholipid antibodies and incidence of venous thrombosis in a cohort of patients with systemic lupus erythematosus.
Somers E; Magder LS; Petri M
J Rheumatol; 2002 Dec; 29(12):2531-6. PubMed ID: 12465147
[TBL] [Abstract][Full Text] [Related]
3. Risk for incident arterial or venous vascular events varies over the course of systemic lupus erythematosus.
Chang ER; Pineau CA; Bernatsky S; Neville C; Clarke AE; Fortin PR
J Rheumatol; 2006 Sep; 33(9):1780-4. PubMed ID: 16832849
[TBL] [Abstract][Full Text] [Related]
4. [Subclinical and clinical manifestations of atherosclerosis in antiphospholipid syndrome].
Reshetniak TM; Seredavkina nV; Mach ES; Aleksandrova EN; Novikov AA; Cherkasova MV; Nasonov EL
Ter Arkh; 2008; 80(10):60-7. PubMed ID: 19105418
[TBL] [Abstract][Full Text] [Related]
5. Incidence studies of systemic lupus erythematosus in Southern Sweden: increasing age, decreasing frequency of renal manifestations and good prognosis.
Ståhl-Hallengren C; Jönsen A; Nived O; Sturfelt G
J Rheumatol; 2000 Mar; 27(3):685-91. PubMed ID: 10743809
[TBL] [Abstract][Full Text] [Related]
6. Association of three systemic lupus erythematosus susceptibility factors, PD-1.3A, C4AQ0, and low levels of mannan-binding lectin, with autoimmune manifestations in Icelandic multicase systemic lupus erythematosus families.
Kristjansdottir H; Saevarsdottir S; Gröndal G; Alarcón-Riquelme ME; Erlendsson K; Valdimarsson H; Steinsson K
Arthritis Rheum; 2008 Dec; 58(12):3865-72. PubMed ID: 19035512
[TBL] [Abstract][Full Text] [Related]
7. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
[TBL] [Abstract][Full Text] [Related]
8. Herpes zoster in juvenile-onset systemic lupus erythematosus: incidence, clinical characteristics and risk factors.
Lee PP; Lee TL; Ho MH; Wong WH; Lau YL
Pediatr Infect Dis J; 2006 Aug; 25(8):728-32. PubMed ID: 16874173
[TBL] [Abstract][Full Text] [Related]
9. Mannose-binding lectin variant alleles and the risk of arterial thrombosis in systemic lupus erythematosus.
Øhlenschlaeger T; Garred P; Madsen HO; Jacobsen S
N Engl J Med; 2004 Jul; 351(3):260-7. PubMed ID: 15254284
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies.
Tektonidou MG; Laskari K; Panagiotakos DB; Moutsopoulos HM
Arthritis Rheum; 2009 Jan; 61(1):29-36. PubMed ID: 19116963
[TBL] [Abstract][Full Text] [Related]
11. The risk of lymphoma development in autoimmune diseases: a meta-analysis.
Zintzaras E; Voulgarelis M; Moutsopoulos HM
Arch Intern Med; 2005 Nov; 165(20):2337-44. PubMed ID: 16287762
[TBL] [Abstract][Full Text] [Related]
12. Familial aggregation of systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune diseases in 1,177 lupus patients from the GLADEL cohort.
Alarcón-Segovia D; Alarcón-Riquelme ME; Cardiel MH; Caeiro F; Massardo L; Villa AR; Pons-Estel BA;
Arthritis Rheum; 2005 Apr; 52(4):1138-47. PubMed ID: 15818688
[TBL] [Abstract][Full Text] [Related]
13. Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus.
Brunner HI; Gladman DD; Ibañez D; Urowitz MD; Silverman ED
Arthritis Rheum; 2008 Feb; 58(2):556-62. PubMed ID: 18240232
[TBL] [Abstract][Full Text] [Related]
14. Young age at onset, renal involvement, and arterial hypertension are of adverse prognostic significance in juvenile systemic lupus erythematosus.
Marini R; Costallat LT
Rev Rhum Engl Ed; 1999 Jun; 66(6):303-9. PubMed ID: 10418057
[TBL] [Abstract][Full Text] [Related]
15. The impact of race and ethnicity on disease severity in systemic lupus erythematosus.
Crosslin KL; Wiginton KL
Ethn Dis; 2009; 19(3):301-7. PubMed ID: 19769013
[TBL] [Abstract][Full Text] [Related]
16. [The role of hyperhomocysteinemia in systemic lupus erythematosus and antiphospholipid syndrome].
Reshetniak TM; Shirokova IE; Lisitskaia TL
Ter Arkh; 2006; 78(6):24-30. PubMed ID: 16881359
[TBL] [Abstract][Full Text] [Related]
17. Incidence of and risk factors for hospitalizations in systemic lupus erythematosus: a prospective study of the Hopkins Lupus Cohort.
Petri M; Genovese M
J Rheumatol; 1992 Oct; 19(10):1559-65. PubMed ID: 1464868
[TBL] [Abstract][Full Text] [Related]
18. Whole blood viscosity and arterial thrombotic events in patients with systemic lupus erythematosus.
Booth S; Chohan S; Curran JC; Karrison T; Schmitz A; Utset TO
Arthritis Rheum; 2007 Jun; 57(5):845-50. PubMed ID: 17530685
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of patients with late onset systemic lupus erythematosus in Turkey.
Sayarlioglu M; Cefle A; Kamali S; Gul A; Inanc M; Ocal L; Aral O; Konice M
Int J Clin Pract; 2005 Feb; 59(2):183-7. PubMed ID: 15854194
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary hypertension in systemic lupus erythematosus: clinical association and survival in 18 patients.
Li EK; Tam LS
J Rheumatol; 1999 Sep; 26(9):1923-9. PubMed ID: 10493670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
